臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 236-260 / 1180 (共48页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-04T06:18:54Z	Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index	Liu C.; Hsu S.; Lin J.; Hwang J.; Liu C.; Yang P.; Lai M.; Chen P.; Chen J.; JIA-HORNG KAO; Chen D.
臺大學術典藏	2021-09-04T06:18:54Z	Viremia Profiles in Hepatitis B Virus Carrier Children With Spontaneous e Antigen Seroconversion: A Case of D?j? Vu?	Lin C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:54Z	The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events	Dai D.-F.; Lin J.-W.; JIA-HORNG KAO; Hsu C.-N.; Chiang F.-T.; Lin J.-L.; Chou Y.-H.; Hsu K.-L.; Tseng C.-D.; Tseng Y.-Z.; Hwang J.-J.
臺大學術典藏	2021-09-04T06:18:54Z	Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors	Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:53Z	High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users	Lin C.-.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:53Z	Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy	Sheng W.-H.; JIA-HORNG KAO; Chen P.-J.; Huang L.-M.; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C.
臺大學術典藏	2021-09-04T06:18:53Z	Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma	Lin C.-L.; Liu C.-H.; Chen W.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:53Z	Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan	Hsu C.-S.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:52Z	Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan	Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Lin C.-L.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:52Z	Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels	Lin C.-L.; Liao L.-Y.; Liu C.-J.; Yu M.-W.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:42Z	Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy	Sheng W.-H.; Hung C.-C.; Wu R.-J.; Wang J.-T.; Chen P.-J.; Chang S.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:42Z	Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges	Liu C.-H.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:42Z	Hepatitis B virus genotype: What should the clinician know?	Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:41Z	Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma	Tsai F.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:41Z	Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients	Wang C.-C.; Liu C.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:40Z	To genotype or not to genotype: Toward an optimal tailoring of treatment of chronic hepatitis B [3]	Lin C.-.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:40Z	Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study	Sheng W.-H.; Hung C.-C.; JIA-HORNG KAO; Chang S.-Y.; Chen M.-Y.; Hsieh S.-M.; Chen P.-J.; Chang S.-C.
臺大學術典藏	2021-09-04T06:12:40Z	APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5]	Su T.-H.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:39Z	Appropriate use of interferon for treatment of chronic hepatitis B	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:39Z	Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]	Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]	Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Hypercholesterolemia in primary biliary cirrhosis [10]	Su T.-C.; Hwang J.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Reply [2]	Lin C.-L.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:37Z	Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations	Liu C.-J.; JIA-HORNG KAO

显示项目 236-260 / 1180 (共48页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51509774 在线人数 : 1140 教育部委托研究计画计画执行:国立台湾大学图书馆